How the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theVeterinary Active Pharmaceutical Ingredients Manufacturing Market?
The escalating count of people possessing pets is projected to expedite the expansion of the veterinary active pharmaceutical ingredients manufacturing market. Pet proprietors are individuals who have acquired or adopted a pet. They provide the vital health amenities for their pets which results in the rising demand for veterinary medications. For instance, data from Animal Medicines Australia, an Australian not-for-profit organization, in 2022 showcased a substantial growth in pet ownership in Australia. The number of pet owners rose to 28,730.8 in 2022, a marked uptick from 39% in 2021. This exhibits a 24% increase, showcasing a robust positive momentum in pet adoption and expenditure on their care. The escalation in pet ownership signifies the growing trend of keeping pets in Australian homes. Consequently, the burgeoning pool of pet owners is fueling the growth of the veterinary active pharmaceutical ingredients manufacturing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
#What Are the Key Projections for the CAGR of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market From 2025 to 2034?
The market for manufacturing veterinary active pharmaceutical ingredients has seen powerful growth in the past few years. The market size is projected to increase from $7.46 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.9%. Factors such as the increase in pet ownership, strict regulatory norms, heightened concentration on animal nutrition, investments in research and development, and the worldwide economic growth have played a significant role in the market’s growth during the historic period.
The market for manufacturing veterinary active pharmaceutical ingredients is predicted to experience robust growth in the coming years. It’s anticipated that it will reach $11.19 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.6%. The expected growth in the forecast period is due to factors such as the evolution in personalized veterinary medicine, market expansion and globalization, emphasis on regulatory conformity, the increasing value of animal welfare, advancements in drug delivery systems, and the growing demand for nutraceuticals. Key trends for the predicted period encompass technological improvement in manufacturing processes, a rise in the outsourcing of API manufacturing, a shift towards biotechnology-based APIs, implementation of digitalization and automation in manufacturing, and the internationalization of the veterinary API market.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942
What Key Market Trends and Innovations Are Shaping the Future of theVeterinary Active Pharmaceutical Ingredients Manufacturing Industry?
A key trend in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. To maintain their standing in the market, major players are focusing on the development of innovative products. For instance, Zoetis Inc., a U.S.-based firm specializing in drugs for pets and livestock, announced in January 2022 the approval by the U.S. FDA of their product, Solensia (frunevetmab injection). This product is intended for the management of osteoarthritis (OA) pain in cats. Uniquely, Solensia is the only injectable monoclonal antibody solution for feline OA pain approved in the U.S., which works by targeting and neutralizing nerve growth factor (NGF), a primary cause of pain in osteoarthritis.
Which Companies Are Leading the Charge in Expanding theVeterinary Active Pharmaceutical Ingredients Manufacturing Market Growth?
Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.
Order Your Report Now For A Swift Delivery:
How is the Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segemented?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7942&type=smpGlobal Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size
Browse Through More Reports Similar to the Gobal Veterinary Active Pharmaceutical Ingredients Manufacturing Maret 2025, By The Business Research Company:
Veterinary Patient Monitoring Equipment Global Market Report 2024
Veterinary Diagnostic Equipment Global Market Report 2024
Veterinary Antibiotics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
